← Evidence map

ArticleJournal of translational medicine2011

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent.

Tomohisa Horibe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 21235734